March 28, 2005 - Natural Products Industry INSIDER
"Flavonoids" References
1. Nuttall SL et al. “An evaluation of the antioxidant activity of a
standardized grape seed extract, Leucoselect..” J Clin Pharm Ther.
23(5):385-9, 1998.
2. Richelle M et al. “Plasma kinetics in man of epicatechin from black
chocolate.” Eur J Clin Nutr 53(1):22-26, 1999.
3. Aviram M et al. "Pomegranate juice flavonoids inhibit low-density
lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic
mice and in humans." Drugs Exp Clin Res. 28, 2-3:49-62, 2002.
4. Manthey JA, Guthrie J. “Antiproliferative activities of citrus
flavonoids against six human cancer cell lines.” J Agric Food Chem.
50(21):5837-43, 2002.
5. Henning M et al. “Bioavailability and antioxidant activity of tea
flavanols after consumption of green tea, black tea, or a green tea extract
supplement.” Am J Clin Nutr. 80, 6:1558-64, 2004.
6. Yasmin T et al. "Antioxidant capacity and safety of various
anthocyanin berry extract formulaions." Res Commun Pharmacol Toxicol.
8:25-36, 2003.
7. Abuja P et al. “Antioxidant and Prooxidant Activities of Elderberry (Sambucus
nigra) in Low-Density Lipoprotein Oxidation.” J of Ag Food Chem
46:4091-96, 1998.
8. Dreosti IE et al. "Inhibition of carcinogenesis by tea: the evidence
from experimental studies." Crit Rev Food Sci Nutr. 37, 8:761-70,
1997. www.sciencedirect.com/science/journal/10408398
9. Williamson G, Crespy V. “A review of the health effects of green tea
catechins in in vivo animal models.” J Nutr. 134(12):3431S-3440S, 2004.
10. Gupta S et al. “Oral consumption of green tea polyphenols inhibits
insulin-like growth factor-I-induced signaling in an autochthonous mouse model
of prostate cancer.” Cancer Res. 64(23):8715-22, 2004.
11. Dufresne CJ, Farnworth ER. “A review of latest research findings on the
health promotion properties of tea.” J Nutr Biochem.12(7):404-421,
2001.
12. Sengupta A et al. “Tea can protect against aberrant crypt foci
formation during azoxymethane induced rat colon carcinogenesis.” J Exp Clin
Cancer Res. 22(2):185-91, 2003.
13. Mukamal KJ et al. "Alcohol consumption and hemostatic factors:
Analysis of the Framingham Offspring Cohort." Circulation. 104:
1367-73, 2001. http://circ.ahajournals.org
14. Negishi H et al. "Black and green tea polyphenols attenuate blood
pressure increases in stroke-prone spontaneously hypertensive rats." J
Nutr. 134(1):38-42, 2004. www.nutrition.org
15. Shoskes D et al. "Quercetin in men with category III chronic
prostatitis: a preliminary prospective, double blind, placebo-controlled
trial." Urology. 54, 6:960-963, 1999. http://www.goldjournal.net/
16. Hamilton-Miller JM. "Anti-cariogenic properties of tea (Camellia
sinensis)." J Med Microbiol. 50, 4:299-302, 2001. www.urbanfischer.de/journals/ijmm/bakteriol.htm
17. Kawai, K et al. "Epigallocatechin gallate, the main component of tea
polyphenol, binds to CD4 and interferes with gp120 binding." J Allergy
Clin Immunol. 112, 5:951-7, 2003. http://www2.us.elsevierhealth.com/scripts/
om.dll/serve?action=searchDB&searchDBfor=home&id=ai
18. Li R et al. “(-)-Epigallocatechin gallate inhibits
lipopolysaccharide-induced microglial activation and protects against
inflammation-mediated dopaminergic neuronal injury.”J Neurosci Res.
78(5):723-31, 2004.
19. Mandel S et al. "Cell signaling pathways in the neuroprotective
actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications
for neurodegenerative diseases." J Neurochem. 88, 6:1555-69, 2004.
20. Choi YT et al. “The green tea polyphenol (-)-epigallocatechin gallate
attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons.”
Life Sci. 70(5):603-14, 2001.
21. Alessio HM et al “Consumption of green tea protects rats from
exercise-induced oxidative stress in kidney and liver” Nutr Res. 22,
10:1177-88, 2002. www.elsevier.com/locate/issn/02715317
22. Fiorini RN et al. “Short-term administration of (-)-epigallocatechin
gallate reduces hepatic steatosis and protects against warm hepatic
ischemia/reperfusion injury in steatotic mice.” Liver Transpl.
11(3):298-308, 2005.
23. Tsuneki H et al. “Effect of green tea on blood glucose levels and serum
proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy
humans.” BMC Pharmacol. 4(1):18, 2004.
24. Nagao T et al. “Ingestion of a tea rich in catechins leads to a
reduction in body fat and malondialdehyde-modified LDL in men” Amer J Clin
Nutr. 81, 1:122-129, 2005. www.ajcn.org
25. Kundu JK, Surh YJ. “Molecular basis of chemoprevention by resveratrol:
NF-kappaB and AP-1 as potential targets.” Mutat Res. 555(1-2):65-80,
2004.
26. Banerjee et al. “Suppression of 7,12-dimethylbenz(a)anthracene-induced
mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB,
cyclooxygenase 2, and matrix metalloprotease 9.” Cancer Res.
62(17):4945-54, 2002. www.cancerres.aacrjournals.org
27. Aziz MH et al. “Cancer chemoprevention by resveratrol: in vitro and in
vivo studies and the underlying mechanisms (review).” Int J Oncol.
23(1):17-28, 2003.
28. Le Corre L et al. “Resveratrol and breast cancer chemoprevention:
Molecular mechanisms.” Mol Nutr Food Res. [Epub ahead of print] Mar 22,
2005. http://www3.interscience.wiley.com/
cgi-bin/abstract/110432503/ABSTRACT
29. Nomoto H et al. “Chemoprevention of colorectal cancer by grape seed
proanthocyanidin is accompanied by a decrease in proliferation and increase in
apoptosis.” Nutr Cancer. 49(1):81-8, 2004.
30. Ye X et al. "The cytotoxic effects of a novel IH636 grape seed
proanthocyanidin extract on cultured human cancer cells." Mol Cell
Biochem. 196, 1-2:99-108, 1999. www.wkap.nl
31. Bagchi D, Sen CK. “Regulation of inducible adhesion molecule expression
in human endothelial cells by grape seed proanthocyanidin extract.” Mol
Cell Biochem. 216(1-2):1-7, 2001.
32. Bagchi D et al. “Protective effects of grape seed proanthocyanidins and
selected antioxidants against TPA-induced hepatic and brain lipid peroxidation
and DNA fragmentation, and peritoneal macrophage activation in mice.”Gen
Pharmacol. 30(5):771-6, 1998.
33. Vigna GB et al. “Effect of a standardized grape seed extract on
low-density lipoprotein susceptibility to oxidation in heavy smokers.” Metabolism.
52(10):1250-7, 2003.
34. Auger C et al. “Phenolics from commercialized grape extracts prevent
early atherosclerotic lesions in hamsters by mechanisms other than antioxidant
effect.” J Agric Food Chem. 52(16):5297-302, 2004.
35. Tyson DA et al. "Acute effects of grape seed extract and
niacin-bound chromium on cardiovascular parameters of normotensive and
hypertensive rats." Res Comm Pharmacol Toxicol. 5, 1-2:91-106, 2000.
36. Nair MP et al. “Grape seed extract proanthocyanidins downregulate HIV-1
entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral
blood mononuclear cells.” Biol Res. 35(3-4):421-31, 2002.
37. Deshane J et al. “Proteomics analysis of rat brain protein modulations
by grape seed extract.” J Agri Food Chem. 52(26):7872-7883, 2004. http://pubs.acs.org/journals/jafcau/index.html
38. Preuss HG et al. "Protective effects of a novel niacin-bound
chromium complex and a grape seed proanthocyanidin extract on advancing age and
various aspects of syndrome X." Ann N Y Acad Sci. 957:250-9, 2002.
39. Watson R. “Reduction of cardiovascular disease risk factors by French
maritime pine bark extract.” Cardiovasc Rev Report. 6:326-329, 1999.
40. Huynh HT, Teel RW. “Selective induction of apoptosis in human mammary
cancer cells (MCF-7) by pycnogenol.” Anticancer Res. 20(4):2417-20,
2000.
41. Liu X et al. “Antidiabetic effect of Pycnogenol French maritime pine
bark extract in patients with diabetes type II.” Life Sci.
75(21):2505-13, 2004.
42. Liu X et al. “Pycnogenol, French maritime pine bark extract, improves
endothelial function of hypertensive patients.” Life Sci. 74(7):855-62,
2004.
43. Peng QL et al. “Pycnogenol protects neurons from amyloid-beta
peptide-induced apoptosis.” Brain Res Mol Brain Res. 104(1):55-65,
2002.
44. Stefanescu M et al. “Pycnogenol efficacy in the treatment of systemic
lupus erythematosus patients.” Phytother Res. 15(8):698-704, 2001.
45. Spadea L, Balestrazzi E. “Treatment of vascular retinopathies with
Pycnogenol.” Phytother Res. 15(3):219-23, 2001.
46. Lau BH et al. “Pycnogenol as an adjunct in the management of childhood
asthma.” J Asthma. 41(8):825-32, 2004.
47. Sharma SC et al. “Pycnogenol inhibits release of histamine from mast
cells.” Phytother Res. 17(1):66-9, 2003.
48. Belcaro G et al. “Prevention of venous thrombosis and thrombophlebitis
in long-haul flights with pycnogenol.” Clin Appl Thromb Hemost.
10(4):373-7, 2004.
49. Kohama T et al. “Analgesic efficacy of French maritime pine bark
extract in dysmenorrhea: an open clinical trial.” J Reprod Med.
49(10):828-32, 2004.
50. Liu FJ et al. “Pycnogenol enhances immune and haemopoietic functions in
senescence-accelerated mice.” Cell Mol Life Sci. 54(10):1168-72, 1998.
51. Roseff SJ. “Improvement in sperm quality and function with French
maritime pine tree bark extract.” J Reprod Med. 47(10):821-4, 2002.
52. Roseff SJ et al. “Oral administration of Pycnogenol affects baseline
human sperm morphology, but not sperm count, motility or functions.” Fertil
Steril. 70(3):S265-66, 1998.
53. Heimann SW. “Pycnogenol for ADHD?” J Am Acad Child Adolesc
Psychiatry. 38(4):357-358, 1999.
54. Pavlovic P. “Improved endurance by use of antioxidants.” Euro Bull
Drug Res. 7(2):26-9, 1999.
55. Sweeney MI et al. “Feeding rats diets enriched in lowbush blueberries
for six weeks decreases ischemia-induced brain damage.” Nutr Neurosci.
5(6):427-31, 2002.
56. Joseph JA et al. Long-term dietary strawberry, spinach, or vitamin E
supplementation retards the onset of age-related neuronal signal-transduction
and cognitive behavioral deficits. J Neurosci. 18, 19:8047-55, 1998. http://www.jneurosci.org
57. Meyers KJ et al. “Antioxidant and antiproliferative activities of
strawberries.” J Agric Food Chem. 51(23):6887-92, 2003.
58. Casto BC et al. Chemoprevention of oral cancer by black raspberries. Anticancer
Res. 22, 6C:4005-15, 2002. http://www.iiar-anticancer.org/index2.htm
59. Harris GK et al. Effects of lyophilized black raspberries on
azoxymethane-induced colon cancer and 8-hydroxy-2'-deoxyguanosine levels in the
Fischer 344 rat. Nutr Cancer.40, 2:125-33, 2001. http://www.leaonline.com/loi/nc
60. Sun J et al. Antioxidant and antiproliferative activities of common
fruits. J Agric Food Chem. 50, 25:7449-54, 2002. http://pubs.acs.org/journals/jafcau
61. McHarg T et al. Influence of cranberry juice on the urinary risk factors
for calcium oxalate kidney stone formation. BJU Int. 92, 7:765-8, 2003. http://www.bjui.org
62. Yamanaka A et al. Inhibitory effects of cranberry juice on attachment of
oral streptococci and biofilm formation. Oral Microbiol Immunol. 19,
3:150-4, 2004. (http://www.blackwellpublishing.com/journal.asp?ref=0902-0055)
63. McHarg T et al. Influence of cranberry juice on the urinary risk factors
for calcium oxalate kidney stone formation. BJU Int. 92, 7:765-8, 2003. http://www.bjui.org
64. Sparrow JR et al. "A2E-epoxides damage DNA in retinal pigment
epithelial cells. J Biol Chem. 278, 20:18207-13, 2003. www.jbc.org
65. Aziz RM et al. “Inhibition of cellular transformation by berry
extracts.” Carcinogen. 22(2):351-56, 2001.
66. Daniel RS et al. Mechanism of action of antiatherogenic and related
effects of Ficus bengalensis Linn. flavonoids in experimental animals. Indian
J Exp Biol. 41, 4:296-303, 2003. http://www.niscair.res.in/ScienceCommunication/
ResearchJournals/rejour/ijeb/ijeb2k3/ijeb_apr03.htm
67. Bagchi D et al. “Anti-angiogenic, antioxidant, and anti-carcinogenic
properties of a novel anthocyanin-rich berry extract formula.” Biochemistry
(Mosc). 69(1):75-80, 2004.
68. Roy S et al. “Anti-angiogenic property of edible berries.” Free
Radic Res. 36(9):1023-31, 2002.
69. Chatterjee A et al. “Inhibition of Helicobacter pylori in vitro by
various berry extracts, with enhanced susceptibility to clarithromycin.” Mol
Cell Biochem. 265(1-2):19-26, 2004.
70. Mathur S et al. "Cocoa products decrease low density lipoprotein
oxidative susceptibility but do not affect biomarkers of inflammation in
humans." J Nutr. 132, 12:3663-7, 2002. www.nutrition.org
71. Rein D et al. "Cocoa inhibits platelet activation and
function." Am J Clin Nutr. 72, 1:30-5, 2000. www.ajcn.org
72. Innes AJ et al. "Dark chocolate inhibits platelet aggregation in
healthy volunteers." Platelets. 14, 5:325-7, 2003. www.tandf.co.uk/journals/titles/09537104.asp
73. Lee CH et al. "Anti-atherogenic effect of citrus flavonoids,
naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and
MCP-1 in high cholesterol-fed rabbits." Biochem Biophys Res Comm.
284, 3:681-8, 2001. www.sciencedirect.com/science/journal/0006291X
74. Ohtsuki K et al. “Effects of long-term administration of hesperidin and
glucosyl hesperidin to spontaneously hypertensive rats.” J Nutr Sci
Vitaminol (Tokyo). 48(5):420-2, 2002.
75. Barrett PH et al. “Hepatocyte apoB-containing lipoprotein secretion is
decreased by the grapefruit flavonoid, naringenin, via inhibition of
MTP-mediated microsomal triglyceride accumulation.” Biochemistry.
42(5):1283-91, 2003.
76. Whitman SC et al. "Nobiletin, a citrus flavonoid isolated from
tangerines, selective inhibits class A scavenger receptor-mediated metabolism of
acetylated LDL by mouse macrophages." Atherosclerosis. [in press
2005] www.elsevier.com/locate/atherosclerosis
77. Vinson JA et al. “Polyphenol antioxidants in citrus juices: in vitro
and in vivo studies relevant to heart disease.” Adv Exp Med Biol.
505:113-22, 2002.
78. Kurowska EM, Manthey JA. "Hypolipidemic effects and absorption of
citrus polymethoxylated flavones in hamsters with diet-induced
hypercholesterolemia." J Agric Food Chem. 52, 10:2879-86, 2004. http://pubs.acs.org/journals/jafcau
79. Tahbaz F et al. “Concentrated pomegranate juice improves lipid profiles
in diabetic patients with hyperlipidemia.” J Med Food. 7(3):305-8,
2004.
80. Aviram M et al. “Pomegranate juice flavonoids inhibit low-density
lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic
mice and in humans.” Drugs Exp Clin Res. 28(2-3):49-62, 2002.
81. Aviram et al. “Pomegranate juice consumption for 3 years by patients
with carotid artery stenosis reduces common carotid intima-media thickness,
blood pressure and LDL oxidation.” Clin Nutr. 23(3):423-33, 2004.
82. Kong AN et al. “Induction of xenobiotic enzymes by the MAP kinase
pathway and the antioxidant or electrophile response element (ARE/EpRE).” Drug
Metab Rev. 33(3-4):255-271, 2001.
83. Bagli E et al. “Luteolin inhibits vascular endothelial growth
factor-induced angiogenesis; inhibition of endothelial cell survival and
proliferation by targeting phosphatidylinositol 3'-kinase activity.” Cancer
Res. 64(21):7936-7946, 2004.
84. Wang W et al. “Individual and interactive effects of apigenin analogs
on G2/M cell-cycle arrest in human colon carcinoma cell lines.” Nutr Cancer.
48(1):106-114, 2004.
85. Sah JF et al. “Epigallocatechin-3-gallate inhibits epidermal growth
factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and
AKT kinases”. J Biol Chem. 279(13):12755-12762, 2004.
86. Kavanagh KT et al. “Green tea extracts decrease carcinogen-induced
mammary tumor burden in rats and rate of breast cancer cell proliferation in
culture.” J Cell Biochem. 82(3):387-398, 2001.
87. Sakata K et al. “Inhibition of inducible isoforms of cyclooxygenase and
nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line.” Cancer
Lett. 199(2):139-145, 2003.
88. Ludwig A et al. “The tea flavonoid epigallocatechin-3-gallate reduces
cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells.”
Biochem Biophys Res Commun. 316(3):659-665, 2004.
89. Anter E et al. “Activation of eNOS by the p38 MAP kinase in response to
black tea polyphenols.” J Biol Chem. 279(45):46637-43, 2004.
90. Bucki R et al. “Flavonoid inhibition of platelet procoagulant activity
and phosphoinositide synthesis.” J Thromb Haemost. 1(8):1820-1828,
2003.
91. Cho SY et al. “Quercetin suppresses proinflammatory cytokines
production through MAP kinases andNF-kappaB pathway in
lipopolysaccharide-stimulated macrophage.” Mol Cell Biochem.
243(1-2):153-160, 2003.
92. Kester A et al. “Capillary Electrophoretic Determination of Resveratrol
in Wines.” J Agri Food Chem. 47(8):3223-27, 1999. http://pubs.acs.org/journals/jafcau/
93. Wang Y et al. “An LC-MS Method for Analyzing Total Resveratrol in Grape
Juice, Cranberry Juice, and in Wine.” J Agri Food Chem. 50(3):431-35,
2002. http://pubs.acs.org/journals/jafcau/